ATE463559T1 - Zelllinie zur produktion von coronaviren - Google Patents
Zelllinie zur produktion von coronavirenInfo
- Publication number
- ATE463559T1 ATE463559T1 AT06792538T AT06792538T ATE463559T1 AT E463559 T1 ATE463559 T1 AT E463559T1 AT 06792538 T AT06792538 T AT 06792538T AT 06792538 T AT06792538 T AT 06792538T AT E463559 T1 ATE463559 T1 AT E463559T1
- Authority
- AT
- Austria
- Prior art keywords
- coronaviruses
- production
- cell line
- relates
- cov
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20051—Methods of production or purification of viral material
- C12N2770/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70202905P | 2005-07-22 | 2005-07-22 | |
| EP05106768 | 2005-07-22 | ||
| PCT/EP2006/064489 WO2007010028A1 (en) | 2005-07-22 | 2006-07-21 | Cell line for producing coronaviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE463559T1 true ATE463559T1 (de) | 2010-04-15 |
Family
ID=35445861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06792538T ATE463559T1 (de) | 2005-07-22 | 2006-07-21 | Zelllinie zur produktion von coronaviren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7888102B2 (de) |
| EP (1) | EP1907536B1 (de) |
| JP (1) | JP5137829B2 (de) |
| KR (1) | KR101274790B1 (de) |
| CN (1) | CN101228267B (de) |
| AT (1) | ATE463559T1 (de) |
| AU (1) | AU2006271666B2 (de) |
| CA (1) | CA2616221C (de) |
| DK (1) | DK1907536T3 (de) |
| WO (1) | WO2007010028A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101206206B1 (ko) * | 2003-07-22 | 2012-11-29 | 크루셀 홀란드 비.브이. | 사스-코로나바이러스에 대한 결합분자 및 그것의 용도 |
| WO2007010028A1 (en) | 2005-07-22 | 2007-01-25 | Crucell Holland B.V. | Cell line for producing coronaviruses |
| WO2008028946A2 (en) | 2006-09-07 | 2008-03-13 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| CN111273016B (zh) * | 2020-02-26 | 2021-06-15 | 浙江诺迦生物科技有限公司 | 一种基于s蛋白配体与ace2受体竞争法层析的冠状病毒快速检测的试剂盒 |
| WO2021207303A1 (en) * | 2020-04-07 | 2021-10-14 | Alsatech, Inc. | Immune stimulation against coronavirus infections |
| WO2021214467A1 (en) * | 2020-04-23 | 2021-10-28 | Cellbio | A diagnostic tool improvement comprising a pathogen binding molecule |
| CN111575242A (zh) * | 2020-06-04 | 2020-08-25 | 广东源心再生医学有限公司 | 一种用于COVID-19药物筛选的iPSC-nCoVN细胞模型及其建立和使用方法 |
| WO2022037699A1 (en) * | 2020-08-21 | 2022-02-24 | Westlake University | Engineered ace2 oligomers and uses thereof |
| WO2022159433A1 (en) | 2021-01-20 | 2022-07-28 | Singh Biotechnology, Llc | Therapeutics directed against coronavirus |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2333425T5 (es) * | 1995-06-15 | 2012-08-28 | Crucell Holland B.V. | Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica |
| US6855544B1 (en) * | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| EP1816205B1 (de) | 1999-05-17 | 2011-08-10 | Crucell Holland B.V. | Rekombinantes Adenovirus auf Basis von Serotyp 48 (Ad48). |
| EP1103610A1 (de) * | 1999-11-26 | 2001-05-30 | Introgene B.V. | Impfstoffherstellung von immortalisierten Säugetierzellinien |
| FR2828405B1 (fr) | 2001-08-09 | 2005-06-24 | Virbac Sa | Vaccin anti-coronavirus |
| NZ538808A (en) | 2002-11-08 | 2008-03-28 | Crucell Holland Bv | Vaccines against west nile virus |
| EP1633775A2 (de) | 2003-06-13 | 2006-03-15 | Crucell Holland B.V. | Antigene peptide des sars-coronavirus und anwendungen davon |
| WO2005012337A2 (en) | 2003-07-15 | 2005-02-10 | Crucell Holland B.V. | Antigenic peptides of sars coronavirus and uses thereof |
| EP1646645A1 (de) | 2003-07-21 | 2006-04-19 | Crucell Holland B.V. | Antigene peptide des sars-coronavirus und anwendungen davon |
| KR101206206B1 (ko) | 2003-07-22 | 2012-11-29 | 크루셀 홀란드 비.브이. | 사스-코로나바이러스에 대한 결합분자 및 그것의 용도 |
| US7396914B2 (en) * | 2003-08-04 | 2008-07-08 | University Of Massachusetts | SARS nucleic acids, proteins, antibodies, and uses thereof |
| WO2005032487A2 (en) * | 2003-10-06 | 2005-04-14 | The Brigham And Women's Hospital, Inc. | Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| WO2007010028A1 (en) | 2005-07-22 | 2007-01-25 | Crucell Holland B.V. | Cell line for producing coronaviruses |
-
2006
- 2006-07-21 WO PCT/EP2006/064489 patent/WO2007010028A1/en active Application Filing
- 2006-07-21 EP EP06792538A patent/EP1907536B1/de active Active
- 2006-07-21 US US11/988,146 patent/US7888102B2/en active Active
- 2006-07-21 CA CA2616221A patent/CA2616221C/en active Active
- 2006-07-21 DK DK06792538.8T patent/DK1907536T3/da active
- 2006-07-21 KR KR1020087001187A patent/KR101274790B1/ko active IP Right Grant
- 2006-07-21 AT AT06792538T patent/ATE463559T1/de active
- 2006-07-21 AU AU2006271666A patent/AU2006271666B2/en not_active Ceased
- 2006-07-21 JP JP2008521977A patent/JP5137829B2/ja not_active Expired - Fee Related
- 2006-07-21 CN CN2006800265222A patent/CN101228267B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080033270A (ko) | 2008-04-16 |
| AU2006271666B2 (en) | 2011-04-07 |
| EP1907536A1 (de) | 2008-04-09 |
| KR101274790B1 (ko) | 2013-06-13 |
| US7888102B2 (en) | 2011-02-15 |
| DK1907536T3 (da) | 2010-07-19 |
| WO2007010028A1 (en) | 2007-01-25 |
| AU2006271666A1 (en) | 2007-01-25 |
| JP5137829B2 (ja) | 2013-02-06 |
| CN101228267B (zh) | 2013-01-23 |
| CA2616221C (en) | 2011-07-05 |
| JP2009502128A (ja) | 2009-01-29 |
| EP1907536B1 (de) | 2010-04-07 |
| CN101228267A (zh) | 2008-07-23 |
| CA2616221A1 (en) | 2007-01-25 |
| US20090098530A1 (en) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE463559T1 (de) | Zelllinie zur produktion von coronaviren | |
| EP3539380A3 (de) | Verbesserte zellzusammensetzung und verfahren zur herstellung davon | |
| WO2010088633A3 (en) | Novel cell lines and methods | |
| CY1113985T1 (el) | Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων | |
| DE602006014676D1 (de) | Festpolymerelektrolyt-membran, herstellungsverfahren dafür und brennstoffzelle | |
| WO2009011546A3 (en) | Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells | |
| WO2009149956A3 (en) | Fusion protein and use thereof | |
| WO2008021156A3 (en) | Antibodies to il-17a | |
| WO2010033906A3 (en) | Efficient induction of pluripotent stem cells using small molecule compounds | |
| GB2451999A (en) | Fuel synthesis | |
| ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
| WO2010031076A3 (en) | Conversion of prenyl derivatives to isoprene | |
| WO2009102569A3 (en) | Cell lines and methods for making and using them | |
| CY1107014T1 (el) | Χρηση θρεπτικου μεσου κυτταροκαλλιεργειας ελευθερου ορου για την παραγωγη il-18bp σε κυτταρα θηλαστικων | |
| WO2010078952A3 (de) | Strukturierte gasdiffusionselektrode für elektrolysezellen | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| ZA200800913B (en) | Process for producing a porous track membrane | |
| EP2408904A4 (de) | Herstellung von umprogrammierten pluripotenten zellen | |
| WO2010128024A3 (en) | Reversibly immortalized cells as well as methods relating hereto | |
| BRPI0912164A2 (pt) | processo para a degradação de lignina. | |
| IN2012DN01968A (de) | ||
| DE602007006258D1 (de) | Ionenaustausch-Membranelektrolyseur | |
| SG170081A1 (en) | Method of patterning and product(s) obtained therefrom | |
| ATE387521T1 (de) | Elektrolysezelle zur herstellung von alkalimetall | |
| MX2012003488A (es) | Proceso para la elaboracion de n-acil-bifenil-alanina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1907536 Country of ref document: EP |